Of note, FGF21 was reported to induce ACE2 expression in adipocytes and renal cells in mouse models (22), which led to our hypothesis that FGF21 upregulation might cause aggravation of COVID-19 via induction of ACE2 in various lifestyle-related diseases. The gene discussed is FGF21; the disease is COVID-19.